002099 海翔药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.216-7.1721.4401.5925.520
总资产报酬率 ROA (%)0.158-5.2791.0721.2534.592
投入资产回报率 ROIC (%)0.175-5.8431.1771.3614.823

边际利润分析
销售毛利率 (%)27.33414.02726.63637.24345.423
营业利润率 (%)0.119-21.3754.0464.91215.994
息税前利润/营业总收入 (%)-1.551-22.908-0.0625.76417.314
净利润/营业总收入 (%)0.709-19.4113.1833.77812.936

收益指标分析
经营活动净收益/利润总额(%)2,227.70234.630226.02495.789102.100
价值变动净收益/利润总额(%)229.74825.229-41.9997.966-5.160
营业外收支净额/利润总额(%)44.4230.425-8.5270.804-0.447

偿债能力分析
流动比率 (X)1.3511.4531.6471.9842.742
速动比率 (X)0.9611.0651.0881.4602.126
资产负债率 (%)28.24525.51027.26323.77018.479
带息债务/全部投入资本 (%)19.12215.74317.30814.636--
股东权益/带息债务 (%)415.697524.765464.876567.126921.992
股东权益/负债合计 (%)254.347292.245266.936320.775441.168
利息保障倍数 (X)0.87915.8870.0167.09012.442

营运能力分析
应收账款周转天数 (天)74.12676.54465.76864.8240.000
存货周转天数 (天)193.301173.972182.408188.7720.000